SCHEMBL28111786

SCHEMBL28111786

CCCCNc1cc2c3c(ccc(Br)c3c1)C(=O)NC2=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 2/20 0.41
HPGD P15428 2/20 0.41
ALOX12 P18054 1/20 0.41
CHEK1 O14757 1/20 0.38
ATG4B Q9Y4P1 6/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
ABL1 P00519 1/20 0.36
F2R P25116 2/20 0.36
AR P10275 1/20 0.36
RGS12 O14924 1/20 0.36
USP2 O75604 1/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36
ATM Q13315 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
TLR9 Q9NR96 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2659189 0.77 KDM4E (0.61) KDM4EALDH1A1HPGDALOX12CHEK1
SCHEMBL1356289 0.72 NPSR1 (0.56) CHEK1MEN1KMT2ARGS12USP2
Butane SCHEMBL11876142 0.70 MEN1 (0.65) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL28495677 0.67 MEN1 (0.60) KDM4EALDH1A1HPGDMEN1KMT2A
SCHEMBL22078662 0.66 KDM4E (0.48) KDM4EALDH1A1HPGDALOX12CHEK1
SCHEMBL27371589 0.65 AR (0.46) KDM4EALDH1A1HPGDALOX12CHEK1
SCHEMBL30517110 0.65 POLB (0.62) KDM4EALDH1A1MEN1KMT2ARGS12
SCHEMBL1888975 0.65 POLB (0.62) KDM4EALDH1A1MEN1KMT2ARGS12
SCHEMBL11435038 0.65 ATG4B (0.49) ALDH1A1ATG4BMEN1KMT2APOLB
SCHEMBL11447330 0.64 MEN1 (0.49) KDM4EALDH1A1ATG4BMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103948595-B Acid imide position or 4-position substituted 1,8-naphthalimide derivative is as the purposes of PARP inhibitor 华侨大学 2017-01-04 CN disclosed